| 生物活性 | |||
|---|---|---|---|
| 描述 | Narmafotinib (AMP-945) is a potent inhibitor of focal adhesion kinase (FAK) with a dissociation constant (KD) of 0.21 nM. It inhibits autophosphorylation of 397Y-FAK in MDA-MB-231 cells with an IC50 of 7 nM and exhibits low overall cellular toxicity, with an IC50 of 2.7 µM in MDA-MB-231 cells[1][2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
1.90mL 0.38mL 0.19mL |
9.48mL 1.90mL 0.95mL |
18.95mL 3.79mL 1.90mL |
| 参考文献 |
|---|
|
[2]Amplia Therapeutics completes single-dose study of AMP945 |